Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-18, Stock:JNJ, The news for the past five days is as follows:
2018-06-11: NEWS1: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS2: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS3: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS4: Investors ready to resuscitate Johnson & Johnson's ailing stock.NEWS5: Dow Movers: MCD, CSCO.NEWS6: Dow Movers: MCD, CSCO.NEWS7: Notable ETF Inflow Detected - ACWI, JPM, XOM, JNJ.NEWS8: Notable ETF Inflow Detected - ACWI, JPM, XOM, JNJ.
2018-06-12: NEWS1: AI And Robotics Are Taking Robotic Surgery To New Levels.NEWS2: [$$] Iqvia? Its CEO Was the Highest Paid Pharma Chief.NEWS3: [$$] Johnson & Johnson Accepts Platinum Equity's $2.1 Billion Offer for LifeScan Business.NEWS4: J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit.NEWS5: J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit.NEWS6: J&J accepts $2.1 billion bid for its LifeScan diabetes business.NEWS7: J&J accepts $2.1 billion offer for its LifeScan unit.NEWS8: Why Dow&apos;s J&J May Try To Sweep Boston Scientific From Stryker.NEWS9: J&J accepts $2.1 bln offer for its LifeScan unit.NEWS10: Johnson & Johnson accepts $2.1B deal for LifeScan business.NEWS11: Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc..NEWS12: Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln.NEWS13: Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln.NEWS14: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS15: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS16: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS17: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS18: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS19: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS20: Lilly & AstraZeneca Scrap Studies on Alzheimer&apos;s Candidate.NEWS21: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS22: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS23: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS24: Alzheimer&apos;s Research Stumbles Again: What&apos;s the Road Ahead?.NEWS25: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS26: Pharma R&D Investments Moderating -- But Still High.NEWS27: Johnson & Johnson To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET.NEWS28: Johnson & Johnson To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET.NEWS29: [$$] AstraZeneca and Eli Lilly scrap Alzheimer’s drug trial.
2018-06-13: NEWS1: Time Warner, Twenty-First Century Fox rise; H&R Block sinks.NEWS2: Deals of the day-Mergers and acquisitions.NEWS3: Toyota on the move, Johnson & Johnson shares up, Hershey under pressure.NEWS4: J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit.NEWS5: J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit.NEWS6: Toyota, Johnson & Johnson and Hershey are the Yahoo Finance charts of the day..NEWS7: J&J (JNJ) Accepts Platinum Equity&apos;s Offer for LifeScan Unit.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2018.NEWS9: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2018.NEWS10: [$$] Ever Heard of Iqvia? Its CEO Made $38 Million.
2018-06-14: NEWS1: Medical Device Industry Outlook - June 2018.NEWS2: Medical Device Industry Outlook - June 2018.NEWS3: Growth & Income Buys | Johnson & Johnson and International Paper.NEWS4: Noteworthy Thursday Option Activity: DE, EOG, JNJ.NEWS5: Noteworthy Thursday Option Activity: DE, EOG, JNJ.NEWS6: 5 AI Biotech Stocks to Bet On Now.NEWS7: Analysts Anticipate OEW Will Reach $37.NEWS8: Analysts Anticipate OEW Will Reach $37.NEWS9: Factors of Influence in 2018, Key Indicators and Opportunity within Southwestern Energy, Johnson & Johnson, Sleep Number, QUALCOMM, Kirkland's, and Grupo Aval Acciones y Valores S.A — New Research Emphasizes Economic Growth.
2018-06-15: NEWS1: LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1.NEWS2: 7 Perfect Dividend Stocks.NEWS3: 7 Perfect Dividend Stocks.NEWS4: 10 Best Stocks to Buy and Hold Forever.NEWS5: 10 Best Stocks to Buy and Hold Forever.NEWS6: [$$] Can Investment Performance Be Predicted?.NEWS7: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS8: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS9: 7 Perfect Dividend Stocks.NEWS10: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS11: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS12: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod.NEWS13: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod.NEWS14: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS15: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck&apos;s Keytruda Gets FDA Nod.NEWS16: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS17: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS18: Estimating The Fair Value Of Johnson & Johnson (NYSE:JNJ).NEWS19: Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed..NEWS20: Growth & Income Buys | Johnson & Johnson and International Paper.NEWS21: Growth & Income Buys | Johnson & Johnson and International Paper.

Answer: Decrease